89 related articles for article (PubMed ID: 3072173)
1. In vitro effects of styrene on cytoskeletal apparatus: an immunocytochemical study.
Malorni W; Formisano G; Iosi F
Drug Chem Toxicol; 1988; 11(4):419-31. PubMed ID: 3072173
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal changes induced in vitro by 2,5-hexanedione: an immunocytochemical study.
Malorni W; Iosi F; Formisano G; Arancia G
Exp Mol Pathol; 1989 Feb; 50(1):50-68. PubMed ID: 2920820
[TBL] [Abstract][Full Text] [Related]
3. Reorganization of keratin intermediate filaments by the drug-induced disruption of microfilaments in cultured human keratinocytes.
Kitajima Y; Inoue S; Yaoita H
J Invest Dermatol; 1986 Nov; 87(5):565-9. PubMed ID: 2430025
[TBL] [Abstract][Full Text] [Related]
4. An immunofluorescence study of the calcium-induced coordinated reorganization of microfilaments, keratin intermediate filaments, and microtubules in cultured human epidermal keratinocytes.
Zamansky GB; Nguyen U; Chou IN
J Invest Dermatol; 1991 Dec; 97(6):985-94. PubMed ID: 1721081
[TBL] [Abstract][Full Text] [Related]
5. Alterations in microtubules, intermediate filaments, and microfilaments induced by microcystin-LR in cultured cells.
Wickstrom ML; Khan SA; Haschek WM; Wyman JF; Eriksson JE; Schaeffer DJ; Beasley VR
Toxicol Pathol; 1995; 23(3):326-37. PubMed ID: 7659955
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features.
Bellomo G; Mirabelli F; Vairetti M; Iosi F; Malorni W
J Cell Physiol; 1990 Apr; 143(1):118-28. PubMed ID: 2318902
[TBL] [Abstract][Full Text] [Related]
7. The cytoskeleton of the cynomolgus monkey trabecular cell. II. Influence of cytoskeleton-active drugs.
Weinreb RN; Ryder MI; Polansky JR
Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1312-7. PubMed ID: 3744723
[TBL] [Abstract][Full Text] [Related]
8. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells.
Timar J; Tang D; Bazaz R; Haddad MM; Kimler VA; Taylor JD; Honn KV
Cell Motil Cytoskeleton; 1993; 26(1):49-65. PubMed ID: 8221907
[TBL] [Abstract][Full Text] [Related]
9. Human gingival fibroblast cytoskeleton is a target for volatile smoke components.
Rota MT; Poggi P; Boratto R
J Periodontol; 2001 Jun; 72(6):709-13. PubMed ID: 11453231
[TBL] [Abstract][Full Text] [Related]
10. Paraquat induces irreversible actin cytoskeleton disruption in cultured human lung cells.
Cappelletti G; Incani C; Maci R
Cell Biol Toxicol; 1994 Aug; 10(4):255-63. PubMed ID: 7895154
[TBL] [Abstract][Full Text] [Related]
11. Microcystin-LR and kinetics of cytoskeletal reorganization in hepatocytes, kidney cells, and fibroblasts.
Khan SA; Wickstrom ML; Haschek WM; Schaeffer DJ; Ghosh S; Beasley VR
Nat Toxins; 1996; 4(5):206-14. PubMed ID: 8946395
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase.
Wiegers W; Just I; Müller H; Hellwig A; Traub P; Aktories K
Eur J Cell Biol; 1991 Apr; 54(2):237-45. PubMed ID: 1908779
[TBL] [Abstract][Full Text] [Related]
13. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: alterations underlying surface bleb formation.
Malorni W; Iosi F; Mirabelli F; Bellomo G
Chem Biol Interact; 1991; 80(2):217-36. PubMed ID: 1934151
[TBL] [Abstract][Full Text] [Related]
14. Dissection of keratin dynamics: different contributions of the actin and microtubule systems.
Wöll S; Windoffer R; Leube RE
Eur J Cell Biol; 2005 Mar; 84(2-3):311-28. PubMed ID: 15819410
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal.
VanWinkle WB; Snuggs M; Miller JC; Buja LM
Cell Motil Cytoskeleton; 1994; 28(2):119-34. PubMed ID: 8087871
[TBL] [Abstract][Full Text] [Related]
16. Bacterial protein toxins acting on the cell cytoskeleton.
Donelli G; Fiorentini C
New Microbiol; 1994 Oct; 17(4):345-62. PubMed ID: 7861993
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeletal interference - A new mode of action for the anticancer drugs camptothecin and topotecan.
Wang X; Tanaka M; Krstin S; Peixoto HS; Moura CCM; Wink M
Eur J Pharmacol; 2016 Oct; 789():265-274. PubMed ID: 27474470
[TBL] [Abstract][Full Text] [Related]
18. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line.
Debal V; Breillout F; Manfait M
Anticancer Res; 1997; 17(2A):1147-54. PubMed ID: 9137463
[TBL] [Abstract][Full Text] [Related]
19. Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells.
Benítez-King G; Huerto-Delgadillo L; Antón-Tay F
J Pineal Res; 1990; 9(3):209-20. PubMed ID: 2082008
[TBL] [Abstract][Full Text] [Related]
20. Role of cytoskeleton in regulating fusion of nucleoli: a study using the activated mouse oocyte model.
Lian HY; Jiao GZ; Wang HL; Tan XW; Wang TY; Zheng LL; Kong QQ; Tan JH
Biol Reprod; 2014 Sep; 91(3):56. PubMed ID: 25061094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
